Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 09-2018 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,487 | 1,769 | 3,905 | 3,255 | 5,449 |
| Marketable Securities | N/A | 27,929 | 49,581 | N/A | N/A |
| Receivables | 198 | 2,150 | 1,788 | 63 | 7 |
| Inventories | 7,087 | 7,971 | 4,705 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 160 |
| TOTAL | $11,257 | $41,221 | $60,613 | $3,511 | $5,694 |
| Non-Current Assets | |||||
| PPE Net | 120 | 151 | 152 | 111 | 121 |
| Investments And Advances | 43,791 | 13,325 | 14,107 | 0 | 196 |
| Intangibles | 0 | 0 | 0 | 1,503 | 60 |
| Other Non-Current Assets | 4,368 | 4,759 | 406 | 27 | 25 |
| TOTAL | $48,279 | $18,235 | $14,665 | $1,641 | $402 |
| Total Assets | $59,536 | $59,456 | $75,278 | $5,152 | $6,096 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,280 | 7,615 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,460 | 11,498 | 8,235 | 347 | 737 |
| Accrued Expenses | N/A | N/A | N/A | 658 | 730 |
| Other current liabilities | 3,770 | 5,786 | 14,281 | N/A | N/A |
| TOTAL | $23,382 | $32,827 | $45,557 | $1,165 | $1,545 |
| Non-Current Liabilities | |||||
| Long Term Debt | 222 | 0 | 925 | 588 | N/A |
| Deferred Revenues | N/A | N/A | 19 | 160 | 46 |
| Other Non-Current Liabilities | 41,090 | 37,682 | 50,236 | 845 | 0 |
| TOTAL | $41,312 | $37,682 | $51,429 | $700 | $3 |
| Total Liabilities | $64,694 | $70,509 | $96,986 | $1,865 | $1,549 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,312 | 48,987 | 1,404 | N/A | N/A |
| Common Shares | 49 | 48 | 37 | 7 | 4 |
| Retained earnings | -225,079 | -226,229 | -171,358 | -85,245 | -75,647 |
| Other shareholders' equity | 1,144 | -79 | -69 | -734 | 0 |
| TOTAL | $-5,158 | $-11,053 | $-21,708 | $3,287 | $4,547 |
| Total Liabilities And Equity | $59,536 | $59,456 | $75,278 | $5,152 | $6,096 |